Prashar Vishal, Bihani Subhash C, Ferrer Jean-Luc, Hosur Madhusoodan V
Solid State Physics Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India.
Institut de Biologie Structurale Jean-Pierre Ebel, Groupe Synchrotron, Commissariat a l'Energie Atomique et aux Energies Alternatives, Centre National de la Recherche Scientifique, Universite de Grenoble Alpes, Grenoble, 38027, France.
Chem Biol Drug Des. 2015 Sep;86(3):302-8. doi: 10.1111/cbdd.12494. Epub 2015 Jan 9.
Although anti-HIV-1 protease drugs nelfinavir (NFV) and saquinavir (SQV) share common functional groups, D30N is a major resistance mutation against NFV but remains susceptible to SQV. We have determined the crystal structure of D30N mutant-tethered HIV-1 protease in complex with SQV to 1.79 Å resolution. Structural analysis showed that SQV forms two direct hydrogen bonds with the main chain atoms of the residues Asp29 and Asp30 that are not observed in the D30N-NFV complex. Apart from maintaining these two main chain hydrogen bonds, the P2-asparagine of SQV forms an additional hydrogen bond to the mutated side chain of the residue 30. These could be the reasons why D30N is not a drug resistance mutation against SQV. This structure supports the previous studies showing that the interactions between a potential inhibitor and backbone atoms of the enzyme are important to maintain potency against drug-resistant HIV-1 protease.
尽管抗HIV-1蛋白酶药物奈非那韦(NFV)和沙奎那韦(SQV)具有共同的官能团,但D30N是针对NFV的主要耐药突变,对SQV仍敏感。我们已确定与SQV复合的D30N突变体连接的HIV-1蛋白酶的晶体结构,分辨率为1.79 Å。结构分析表明,SQV与D29和D30残基的主链原子形成两个直接氢键,而在D30N-NFV复合物中未观察到这种情况。除了维持这两个主链氢键外,SQV的P2-天冬酰胺与30位残基的突变侧链形成额外的氢键。这些可能是D30N不是针对SQV的耐药突变的原因。该结构支持先前的研究,表明潜在抑制剂与酶的主链原子之间的相互作用对于维持对耐药HIV-1蛋白酶的效力很重要。